WO2001003678A3 - Transdermales therapeutisches system zur anwendung von tolterodin - Google Patents

Transdermales therapeutisches system zur anwendung von tolterodin Download PDF

Info

Publication number
WO2001003678A3
WO2001003678A3 PCT/EP2000/006605 EP0006605W WO0103678A3 WO 2001003678 A3 WO2001003678 A3 WO 2001003678A3 EP 0006605 W EP0006605 W EP 0006605W WO 0103678 A3 WO0103678 A3 WO 0103678A3
Authority
WO
WIPO (PCT)
Prior art keywords
tolterodine
utilization
therapeutic system
transdermal therapeutic
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/006605
Other languages
English (en)
French (fr)
Other versions
WO2001003678A2 (de
Inventor
Thomas Struengmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Priority to AU64340/00A priority Critical patent/AU6434000A/en
Priority to EP00951373A priority patent/EP1194134A1/de
Publication of WO2001003678A2 publication Critical patent/WO2001003678A2/de
Publication of WO2001003678A3 publication Critical patent/WO2001003678A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Die Erfindung betrifft ein wirkstoffhaltiges transdermales System zur Anwendung von Tolterodin, 5-Hydroxymethyltolterodin, deren pharmazeutisch unbedenklichen Salze oder ein Gemisch aus diesen.
PCT/EP2000/006605 1999-07-13 2000-07-12 Transdermales therapeutisches system zur anwendung von tolterodin Ceased WO2001003678A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU64340/00A AU6434000A (en) 1999-07-13 2000-07-12 Transdermal therapeutic system for the utilization of tolterodine
EP00951373A EP1194134A1 (de) 1999-07-13 2000-07-12 Transdermales therapeutisches system zur anwendung von tolterodin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999132651 DE19932651A1 (de) 1999-07-13 1999-07-13 Transdermales therapeutisches System zur Anwendung von Tolterodin
DE19932651.7 1999-07-13

Publications (2)

Publication Number Publication Date
WO2001003678A2 WO2001003678A2 (de) 2001-01-18
WO2001003678A3 true WO2001003678A3 (de) 2001-05-25

Family

ID=7914576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/006605 Ceased WO2001003678A2 (de) 1999-07-13 2000-07-12 Transdermales therapeutisches system zur anwendung von tolterodin

Country Status (4)

Country Link
EP (1) EP1194134A1 (de)
AU (1) AU6434000A (de)
DE (1) DE19932651A1 (de)
WO (1) WO2001003678A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
US9085507B2 (en) 2009-05-11 2015-07-21 Ratiopharm Gmbh Desfesoterodine in the form of a tartaric acid salt
WO2012017892A1 (ja) * 2010-08-03 2012-02-09 久光製薬株式会社 貼付剤及びその粘着力増強方法
CN108836635B (zh) * 2016-02-03 2020-09-15 山东东贝医药科技有限公司 抗炎抑菌医用敷料

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003067A1 (en) * 1996-07-19 1998-01-29 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
WO2000012070A1 (en) * 1998-08-27 2000-03-09 Pharmacia & Upjohn Ab Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
WO2000012069A1 (en) * 1998-08-27 2000-03-09 Pharmacia & Upjohn Ab Therapeutic formulation for administering tolterodine with controlled release
WO2000069421A2 (de) * 1999-05-18 2000-11-23 Schwarz Pharma Ag Transdermales therapeutisches system (tts) tolterodin enthaltend

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003067A1 (en) * 1996-07-19 1998-01-29 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
WO2000012070A1 (en) * 1998-08-27 2000-03-09 Pharmacia & Upjohn Ab Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
WO2000012069A1 (en) * 1998-08-27 2000-03-09 Pharmacia & Upjohn Ab Therapeutic formulation for administering tolterodine with controlled release
WO2000069421A2 (de) * 1999-05-18 2000-11-23 Schwarz Pharma Ag Transdermales therapeutisches system (tts) tolterodin enthaltend

Also Published As

Publication number Publication date
EP1194134A1 (de) 2002-04-10
AU6434000A (en) 2001-01-30
DE19932651A1 (de) 2001-01-18
WO2001003678A2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
MXPA03007712A (es) Sales farmaceuticas.
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
NZ512883A (en) 2-oxoquinoline compounds and medicinal uses thereof
FI960556A7 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärje stelmä
AU5323398A (en) Contour of a transdermal therapeutic system
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
MXPA03007903A (es) Sistema terapeutico transdermico altamente flexible con nicotina como ingrediente activo.
AU2002308289A1 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
CA2338066A1 (en) Treatment of dyskinesia
AU2002210462A1 (en) Transdermal therapeutic system for treating restless-legs-syndrome
AU6995700A (en) Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers
ID24228A (id) (+)norcisaprida yang berguna untuk gangguan tertular 5-ht3 dan 5-ht4
FI950165L (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
EP1090639A3 (de) Pharmazeutische Zusammensetzung enthaltend einen progestationäle Kortikoid und einen selektiven Östrogenrezeptormodulator
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ZA200304928B (en) Medicament containing a polyamine as an active substance.
CA2394471A1 (en) External preparation for treating pruritus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000951373

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10030786

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 64340/00

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000951373

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000951373

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP